• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫组化检测 MTAP 和 BAP1 蛋白缺失在间皮瘤诊断中的应用:与 9p21 FISH 和 BAP1 免疫组化的比较。

Immunohistochemical detection of MTAP and BAP1 protein loss for mesothelioma diagnosis: Comparison with 9p21 FISH and BAP1 immunohistochemistry.

机构信息

Department of Pathology, Fukuoka University Hospital and School of Medicine, 7-45-1 Nanakuma, Jonan-ku, Fukuoka 814-0180, Japan; Department of Anatomic Pathology, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan; Department of Clinical Radiology, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.

Department of Pathology, Fukuoka University Hospital and School of Medicine, 7-45-1 Nanakuma, Jonan-ku, Fukuoka 814-0180, Japan.

出版信息

Lung Cancer. 2017 Feb;104:98-105. doi: 10.1016/j.lungcan.2016.12.017. Epub 2016 Dec 23.

DOI:10.1016/j.lungcan.2016.12.017
PMID:28213009
Abstract

OBJECTIVES

Differentiating malignant pleural mesothelioma (MPM) from reactive mesothelial hyperplasia (RMH) is still challenging. Detection of homozygous deletion (HD) of 9p21 region including p16 (p16) by fluorescence in situ hybridization (FISH) and immunohistochemical detection of loss of BRCA1 associated protein 1 (BAP1), are reliable markers for MPM diagnosis. However, not all laboratories are equipped to perform 9p21 FISH; immunohistochemistry (IHC) is a more common and feasible technique. Thus, we sought to develop a IHC-based method that could predict the deletion of p16 in MPM in concordance with 9p21 FISH.

MATERIALS AND METHODS

We examined the expression of the 9p21.3-related proteins (p14, p15, p16, and methylthioadenosine phosphorylase (MTAP)) and BAP1 using IHC in 51 MPM and 25 RMH cases, and assessed their correlation with HD of p16 detected by FISH. The diagnostic usefulness of IHC of the 9p21.3-related proteins and BAP1 and their combinations was assessed using the cut-off values set by receiver operating characteristic (ROC) analysis.

RESULTS

Among the 9p21.3-related proteins, MTAP IHC findings showed best concordance with 9p21 FISH results (kappa coefficient of 0.69) and a specificity of 100%. We also examined the combinations of MTAP IHC with the other products. The loss of p16 and MTAP had better concordance (kappa coefficient of 0.71), although lower specificity (85%). For differentiating MPM from RMH, only MTAP showed 100% specificity among the 9p21.3-related proteins, as did BAP1 IHC and 9p21 FISH. Among BAP1 combinations, only that of BAP1 with MTAP showed 100% specificity. Its sensitivity was 76.5%, which was lower than BAP1 IHC and 9p21 FISH combination (84.3%), but higher than BAP1 IHC alone (60.8%) or 9p21 FISH alone (60.8%).

CONCLUSIONS

A combination of MTAP or BAP1 loss detected by IHC can likely detect MPM with good sensitivity and 100% specificity, and serve as useful ancillary IHC for discriminating MPM from RMH.

摘要

目的

区分恶性胸膜间皮瘤(MPM)和反应性间皮增生(RMH)仍然具有挑战性。荧光原位杂交(FISH)检测 9p21 区域的纯合缺失(HD),包括 p16(p16),以及免疫组化检测 BRCA1 相关蛋白 1(BAP1)缺失,是 MPM 诊断的可靠标志物。然而,并非所有实验室都具备进行 9p21 FISH 的条件;免疫组化(IHC)是一种更为常见且可行的技术。因此,我们试图开发一种基于 IHC 的方法,该方法可以预测 MPM 中 p16 的缺失情况,与 9p21 FISH 结果一致。

材料与方法

我们在 51 例 MPM 和 25 例 RMH 病例中,使用 IHC 检测了 9p21.3 相关蛋白(p14、p15、p16 和甲基硫腺苷磷酸化酶(MTAP))和 BAP1 的表达情况,并评估了它们与 FISH 检测到的 p16 HD 的相关性。使用受试者工作特征(ROC)分析设定的截止值评估 9p21.3 相关蛋白和 BAP1 的 IHC 及其组合的诊断效用。

结果

在 9p21.3 相关蛋白中,MTAP IHC 结果与 9p21 FISH 结果的一致性最佳(kappa 系数为 0.69),特异性为 100%。我们还检查了 MTAP IHC 与其他产物的组合。p16 和 MTAP 的缺失具有更好的一致性(kappa 系数为 0.71),尽管特异性较低(85%)。在区分 MPM 和 RMH 方面,9p21.3 相关蛋白中只有 MTAP 具有 100%的特异性,BAP1 IHC 和 9p21 FISH 也是如此。在 BAP1 组合中,只有 BAP1 与 MTAP 的组合具有 100%的特异性。其灵敏度为 76.5%,低于 BAP1 IHC 和 9p21 FISH 组合(84.3%),但高于 BAP1 IHC 单独(60.8%)或 9p21 FISH 单独(60.8%)。

结论

通过 IHC 检测到的 MTAP 或 BAP1 缺失可能具有良好的灵敏度和 100%的特异性,有助于区分 MPM 和 RMH,可作为有用的辅助 IHC 方法。

相似文献

1
Immunohistochemical detection of MTAP and BAP1 protein loss for mesothelioma diagnosis: Comparison with 9p21 FISH and BAP1 immunohistochemistry.免疫组化检测 MTAP 和 BAP1 蛋白缺失在间皮瘤诊断中的应用:与 9p21 FISH 和 BAP1 免疫组化的比较。
Lung Cancer. 2017 Feb;104:98-105. doi: 10.1016/j.lungcan.2016.12.017. Epub 2016 Dec 23.
2
Highly expressed EZH2 in combination with BAP1 and MTAP loss, as detected by immunohistochemistry, is useful for differentiating malignant pleural mesothelioma from reactive mesothelial hyperplasia.免疫组织化学检测到 EZH2 高表达,结合 BAP1 和 MTAP 缺失,有助于鉴别恶性胸膜间皮瘤与反应性间皮增生。
Lung Cancer. 2019 Apr;130:187-193. doi: 10.1016/j.lungcan.2019.02.004. Epub 2019 Feb 27.
3
A combination of MTAP and BAP1 immunohistochemistry is effective for distinguishing sarcomatoid mesothelioma from fibrous pleuritis.MTAP 和 BAP1 免疫组化联合检测可有效鉴别肉瘤样间皮瘤与纤维性胸膜炎。
Lung Cancer. 2018 Nov;125:198-204. doi: 10.1016/j.lungcan.2018.09.019. Epub 2018 Sep 26.
4
A combination of MTAP and BAP1 immunohistochemistry in pleural effusion cytology for the diagnosis of mesothelioma.胸腔积液细胞学中 MTAP 和 BAP1 免疫组化联合用于间皮瘤的诊断。
Cancer Cytopathol. 2018 Jan;126(1):54-63. doi: 10.1002/cncy.21928. Epub 2017 Oct 20.
5
BAP1 immunohistochemistry and p16 FISH results in combination provide higher confidence in malignant pleural mesothelioma diagnosis: ROC analysis of the two tests.BAP1免疫组化和p16荧光原位杂交结果联合使用可提高恶性胸膜间皮瘤诊断的可信度:两种检测方法的ROC分析
Pathol Int. 2016 Oct;66(10):563-570. doi: 10.1111/pin.12453. Epub 2016 Sep 11.
6
Fluorescence in situ hybridization detection of chromosome 22 monosomy in pleural effusion cytology for the diagnosis of mesothelioma.胸腔积液细胞学中 22 号染色体单体性荧光原位杂交检测在间皮瘤诊断中的应用。
Cancer Cytopathol. 2021 Jul;129(7):526-536. doi: 10.1002/cncy.22409. Epub 2021 Jan 25.
7
Hemizygous loss of NF2 detected by fluorescence in situ hybridization is useful for the diagnosis of malignant pleural mesothelioma.荧光原位杂交检测 NF2 杂合性缺失有助于恶性胸膜间皮瘤的诊断。
Mod Pathol. 2020 Feb;33(2):235-244. doi: 10.1038/s41379-019-0309-6. Epub 2019 Jun 23.
8
Genomic-based ancillary assays offer improved diagnostic yield of effusion cytology with potential challenges in malignant pleural mesothelioma.基于基因组的辅助检测提高了胸腔积液细胞学诊断的阳性率,但在恶性胸膜间皮瘤中存在潜在的挑战。
Pathol Int. 2020 Sep;70(9):671-679. doi: 10.1111/pin.12973. Epub 2020 Jun 15.
9
Challenges and limitation of MTAP immunohistochemistry in diagnosing desmoplastic mesothelioma/sarcomatoid pleural mesothelioma with desmoplastic features.在诊断具有间皮瘤特征的促纤维增生性间皮瘤/肉瘤样胸膜间皮瘤时,MTAP 免疫组化的挑战和局限性。
Ann Diagn Pathol. 2022 Oct;60:152004. doi: 10.1016/j.anndiagpath.2022.152004. Epub 2022 Jun 30.
10
The significance of BAP1 and MTAP/CDKN2A expression in well-differentiated papillary mesothelial tumour: a series of 21 cases and a review of the literature.BAP1 和 MTAP/CDKN2A 表达在分化良好的乳头状间皮瘤中的意义:21 例系列病例及文献复习。
Pathology. 2024 Aug;56(5):662-670. doi: 10.1016/j.pathol.2024.02.016. Epub 2024 May 9.

引用本文的文献

1
Molecular Insights into Pleural Mesothelioma: Unveiling Pathogenic Mechanisms and Therapeutic Opportunities.胸膜间皮瘤的分子见解:揭示致病机制与治疗机遇
Diagnostics (Basel). 2025 May 24;15(11):1323. doi: 10.3390/diagnostics15111323.
2
Diagnostic Challenges in the Pathological Approach to Pleural Mesothelioma.胸膜间皮瘤病理诊断方法中的挑战
Cancers (Basel). 2025 Feb 1;17(3):481. doi: 10.3390/cancers17030481.
3
Analysis of TERT mRNA Levels and Clinicopathological Features in Patients with Peritoneal Mesothelioma.腹膜间皮瘤患者端粒酶逆转录酶(TERT)mRNA水平与临床病理特征分析
Cancers (Basel). 2025 Jan 14;17(2):252. doi: 10.3390/cancers17020252.
4
MTAP and p16 IHC as Markers for CDKN2A/B Loss in Meningiomas.MTAP和p16免疫组化作为脑膜瘤中CDKN2A/B缺失的标志物
Cancers (Basel). 2024 Sep 27;16(19):3299. doi: 10.3390/cancers16193299.
5
Comparing loss of p16 and MTAP expression in detecting CDKN2A homozygous deletion in pleomorphic xanthoastrocytoma.比较 p16 和 MTAP 表达缺失在检测多形性黄色星形细胞瘤中 CDKN2A 纯合性缺失中的作用。
J Neuropathol Exp Neurol. 2024 Dec 1;83(12):1003-1009. doi: 10.1093/jnen/nlae076.
6
A Rare Case of Pleural Epithelioid Mesothelioma With a Prominent Myxoid Stroma Reported With Morphology, Fluorescent In Situ Hybridization, and Ultrastructural Findings.一例罕见的伴有显著黏液样基质的胸膜上皮样间皮瘤,报告形态学、荧光原位杂交及超微结构结果
Cureus. 2024 Jun 12;16(6):e62212. doi: 10.7759/cureus.62212. eCollection 2024 Jun.
7
The World Health Organization Reporting System for Lung Cytopathology-A Review of the First Edition.世界卫生组织肺细胞病理学报告系统——第一版综述
J Clin Transl Pathol. 2024 Jan-Mar;4(1):18-35. doi: 10.14218/jctp.2023.00068. Epub 2024 Mar 11.
8
Loss of methylthioadenosine phosphorylase immunoreactivity correlates with poor prognosis and elevated uptake of C-methionine in IDH-mutant astrocytoma.甲基硫腺苷磷酸化酶免疫反应缺失与 IDH 突变星形细胞瘤的不良预后和 C-蛋氨酸摄取增加相关。
J Neurooncol. 2024 Jun;168(2):355-365. doi: 10.1007/s11060-024-04661-y. Epub 2024 Apr 1.
9
Diagnostic Challenges during Inflammation and Cancer: Current Biomarkers and Future Perspectives in Navigating through the Minefield of Reactive versus Dysplastic and Cancerous Lesions in the Digestive System.炎症与癌症期间的诊断挑战:当前生物标志物以及消化系统中反应性、发育异常和癌性病变雷区导航的未来展望
Int J Mol Sci. 2024 Jan 19;25(2):1251. doi: 10.3390/ijms25021251.
10
Comparison of Immunohistochemistry, Next-generation Sequencing and Fluorescence In Situ Hybridization for Detection of MTAP Loss in Pleural Mesothelioma.比较免疫组织化学、下一代测序和荧光原位杂交在胸膜间皮瘤中检测 MTAP 缺失的应用。
Mod Pathol. 2024 Mar;37(3):100420. doi: 10.1016/j.modpat.2023.100420. Epub 2024 Jan 5.